Literature DB >> 5573770

Immunotherapy experiments with a methylcholanthrene-induced guinea pig liposarcoma.

F R Eilber, E C Holmes, D L Morton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5573770

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Immunotherapy combined with primary resection of murine fibrosarcoma: correlation of immunological status of the host with prevention of metastases.

Authors:  E A Godrick; J S Michaelson; R Vanwijck; R E Wilson
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

2.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

3.  Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.

Authors:  Donald L Morton; Eddy C Hsueh; Richard Essner; Leland J Foshag; Steven J O'Day; Anton Bilchik; Rishab K Gupta; Dave S B Hoon; Mepur Ravindranath; J Anne Nizze; Guy Gammon; Leslie A Wanek; He-Jing Wang; Robert M Elashoff
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

4.  Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

5.  The induction of tumours in the guinea-pig with methylcholanthrene and diethylnitrosamine and their propagation in vivo and in vitro.

Authors:  M M Dale; G C Easty; R Tchao; H Desai; M Andjargholi
Journal:  Br J Cancer       Date:  1973-06       Impact factor: 7.640

6.  BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.

Authors:  R W Baldwin; M V Pimm
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.